Latest Issue of Science News


A new way to lower cholesterol

Cholesterol-lowering drugs known as statins are at the forefront of the fight against heart disease. They work by blocking the synthesis of cholesterol inside cells. This, in turn, causes cells to produce more of a compound known as low-density-lipoprotein receptor, or LDLr, which plucks dangerous cholesterol from the bloodstream.

Despite the success of statins, they don't work for everyone. Now, a team of researchers with GlaxoSmithKline in Les Ulis, France, has found another way of reducing cholesterol. Working with cell cultures, the researchers began by genetically engineering human cells to express a fluorescent protein when the DNA that normally activates the LDLr gene is active. Then, they searched for compounds that increased the cells' fluorescence. Such chemicals, they reasoned, would boost LDLr activity in normal cells.

Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.

This article is available only to subscribing members. Join SSP today or Log in.